Virax Biolabs surges on launch of monkeypox rapid antigen test
20/09/2022 13:56
** Virax Biolabs Group VRAX.O shares jump 38% to $3.42
premarket
** Co introduces monkeypox virus antigen rapid test kit in
markets accepting the CE mark, which is a manufacturer's
declaration that the test complies with European norms (https://refini.tv/3f2Obcy)
** Test kits typically provide results in 15 minutes - VRAX
** Co launched PCR detection kits for monkeypox and
chickenpox in Europe in July urn:newsml:reuters.com:*:nL4N2Z72VK
** Up to Monday's close, stock had fallen 50.6% YTD from its
July IPO price of $5 urn:newsml:reuters.com:*:nGNX4Y5pbG
(Reporting by Leroy Leo in Bengaluru)
((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))